Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Moodys
Johnson and Johnson
Dow
Harvard Business School

Last Updated: October 6, 2022

Fougera Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for FOUGERA, and what generic and branded alternatives to FOUGERA drugs are available?

FOUGERA has one hundred and seventeen approved drugs.



Summary for Fougera
US Patents:0
Tradenames:55
Ingredients:47
NDAs:117

Drugs and US Patents for Fougera

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms SULFACETAMIDE SODIUM sulfacetamide sodium LOTION;TOPICAL 077015-001 Nov 17, 2006 AB RX No No See Plans and Pricing See Plans and Pricing
Fougera Pharms TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 085692-003 Approved Prior to Jan 1, 1982 AT RX Yes Yes See Plans and Pricing See Plans and Pricing
Fougera Pharms Inc FLUOCINOLONE ACETONIDE fluocinolone acetonide OINTMENT;TOPICAL 088168-001 Dec 16, 1982 AT RX No No See Plans and Pricing See Plans and Pricing
Fougera Pharms CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; clotrimazole CREAM;TOPICAL 075502-001 Jun 5, 2001 AB RX No No See Plans and Pricing See Plans and Pricing
Fougera Pharms CLOTRIMAZOLE clotrimazole CREAM;TOPICAL 078338-001 Sep 2, 2008 AB RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Fougera

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,985,850 See Plans and Pricing
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,792,753 See Plans and Pricing
Fougera Pharms ACLOVATE alclometasone dipropionate CREAM;TOPICAL 018707-001 Dec 14, 1982 4,124,707 See Plans and Pricing
Fougera Pharms CUTIVATE fluticasone propionate LOTION;TOPICAL 021152-001 Mar 31, 2005 7,300,669 See Plans and Pricing
Fougera Pharms CUTIVATE fluticasone propionate OINTMENT;TOPICAL 019957-001 Dec 14, 1990 4,335,121*PED See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for FOUGERA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Gel 3% ➤ Subscribe 2009-12-16
➤ Subscribe Lotion 0.05% ➤ Subscribe 2008-07-28
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Medtronic
Colorcon
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.